For MyEyeDr. The Patient Experience, Boosted by New Tech and Investment, Tops 2020 Plan

By Staff
Tuesday, January 21, 2020 12:27 AM NEW YORK—Beginning its next chapter, armed with the investment and health care perspectives from its new financial partner at Goldman SachsMyEyeDr. (MED) is viewing the future as one which will amplify its efforts to put the patient experience front and center. Its leadership team is poised to employ technology in a range of ways, from those that streamline and make patient service more actionable, to an approach that further develops professional paths for its optometrists and raises vision care’s profile and awareness among patients and other provider groups in the health care field.

AOA Receives Department of Justice Approval to Expand Group Purchasing Activities for Its AOAExcel Members

By Staff
Tuesday, January 21, 2020 12:24 AM WASHINGTON, D.C.—The Department of Justice (DOJ) announced January 15 that it will not challenge a proposal by the American Optometric Association to expand its group purchasing organization’s (GPO) activities to include the purchase of optometric products for resale to consumers, specifically eyeglass lenses, frames, and contact lenses. According to a statement issued by the DOJ, the proposed expansion of the AOA’s purchasing activities, conducted through a program known as AOAExcel, is “unlikely to produce anticompetitive effects.” Moreover, the expansion could produce discounts for the Association’s members and ultimately lead to lower prices for optometric products for consumers, the DOJ said.

De Rigo REM’s National Sales Meeting Emphasizes Unity, Highlights FILA Launch

By Staff
Tuesday, January 21, 2020 12:21 AM MANHATTAN BEACH, Calif.—The theme at De Rigo REM’s 2020 National Sales meeting, which took place at the West Drift Marriott from Jan 9–11, was “One Company, One Team, One Message.”

Mojo Vision Is Developing a New Type of Smart Contact Lens

By Staff
Tuesday, January 21, 2020 12:18 AM SARATOGA, Calif.—Mojo Vision, a Silicon Valley-based startup, announced last week that it is building a new type of smart contact lens called Mojo Lens.

Vision Source Announces Mobile Vision Clinic Tour Across 13 Cities

By Staff
Tuesday, January 21, 2020 12:15 AM NEW YORK—Vision Source has announced a mobile vision clinic tour of 13 major U.S. cities in 2020 to raise awareness for the importance of an annual comprehensive eye exam. Along the tour, Vision Source doctors and staff will provide free exams and corrective eyewear to families across the country who do not have access to vision care. The tour began in Charlotte, North Carolina last week and will also travel to Atlanta, Boston, Chicago, Dallas, Denver, Houston, Indianapolis, Los Angeles, Phoenix, Seattle, St. Louis and Washington D.C. Locally licensed doctors within the Vision Source network will staff the events, which will be equipped to support all aspects of a comprehensive eye exam.

The Vision Council Notes That U.S.-China Trade Agreement Will Result in Tariff Reductions on Certain Optical Products

By Staff
Friday, January 17, 2020 12:27 AM ALEXANDRIA, Va.—The Vision Council announced Thursday that the U.S. and China have signed a phase one trade deal that requires structural reforms to China’s economic and trade regimes. The agreement also will lead to a modification of a portion of the existing Section 301 China tariffs. This modification is “a point of interest” to association members who import Chinese-origin product, The Vision Council noted. The overall reforms will be seen in the areas of intellectual property, forced technology transfers, financial services, agriculture, and currency and financial exchanges. In addition, China has agreed to purchase substantial quantities of U.S. origin goods and services in the coming years.

Three Execs join BrightBenefits, Rounding Out the New Company's Executive Leadership Team

By Staff
Friday, January 17, 2020 12:24 AM NASHVILLE, Tenn.—BrightBenefits, a new employee benefits company formed last year, announced several new additions to its executive leadership team. Under the leadership of president Danny Bentley, and along with Tim Carney, executive vice president and chief sales officer, these additions will help further establish the company in the dental and vision insurance industries and strategically position it in the marketplace, the company said. Jennifer Hill, Brynn Ray and Jena Wendel are the new executives who will bring a range of experience to their new roles. VMail reported about the establishment of BrightBenefits late last year. BrightBenefits, a national dental and vision insurance business, is a strategic partnership between National Guardian Life Insurance Company (NGL) and Insurance Capital Group (ICG). NGL and ICG, through its Federal Life Group, Inc. affiliate, have jointly developed and launched BrightBenefits. Policies will be issued by NGL and by Commercial Travelers Insurance Company. 

Mondottica International Names Tony Pessok CEO, as Founder Michael Jardine Steps Down, Continues on the Board as Honorary Chairman

By Staff
Friday, January 17, 2020 12:21 AM LONDON—Mondottica International announced that its founder and CEO, Michael Jardine, has stepped down from his CEO role effective January 1, 2020. The CEO role has been immediately assumed by Tony Pessok, chief commercial officer, who joined the Group from Perry Ellis International earlier last year, as VMail reported. Jardine will continue as a substantial shareholder and member of the board of directors with the title of founder and honorary chairman. He will continue to work from his office at Mondottica’s headquarters in Hong Kong. Stated Jardine, “We started Mondottica two decades ago and there is a nice symmetry in handing over the reins on the cusp of the new decade to come. We have accomplished much in 20 years and I am now excited to see the new C-Suite bring it to an even greater level in the future.” 

Allergan Teams Up With Von Miller to Raise Awareness of Glaucoma's Impact on Daily Living

By Staff
Friday, January 17, 2020 12:18 AM DUBLIN—Allergan plc (NYSE: AGN), a global pharmaceutical company with more than 70 years of heritage in eyecare, announced a partnership with Von Miller, a former Super Bowl MVP, Denver Broncos linebacker and advocate for healthy vision, to shine a light on the millions of people living with glaucoma. As an ambassador for the “My Glaucoma” campaign, Miller will address the misunderstandings and impact of glaucoma and encourage those with the disease, and their caregivers, to take early action, according to the announcement this week. This includes going to the doctor regularly and taking medications as prescribed. 

VMAIL Scheduling Note for Jan. 20, 2020

By Staff
Friday, January 17, 2020 12:15 AM NEW YORK—Due to the Martin Luther King Jr. holiday there will be no VMAIL issued on Monday, Jan. 20, 2020. VMAIL is scheduled to resume its regular schedule on Tuesday, Jan. 21. To catch up on all the week’s news, look for VMAIL Weekend coming your way this Saturday, Jan. 18, with all of its regular features including Today’s Read and ICYMI. And on Monday, Jan. 20, look for Vision Monday’s January digital edition on VisionMonday.com.

Luxottica Wholesale N.A. Invests in Independent Optical Sales Division to Focus on Brands

By Staff
Thursday, January 16, 2020 12:24 AM NEW YORK—Luxottica Wholesale N.A. said it is investing in the evolution of its independent optical sales division, which accounts for the largest component of the company’s overall sales force. The independent optical sales division is made up of approximately 300 salespeople who serve ECPs throughout North America with Luxottica’s brands. "These changes will strengthen Luxottica’s consultative approach to ECPs by putting greater focus on brands and customer support," a company spokesperson told VMAIL, adding, "the evolution is designed to empower Luxottica’s talent and rally them together as part of one family. The primary change will be a greater focus on brands."

CooperVision Announces ‘Brilliant Futures Myopia Management Program' in Advance of U.S. Launch of MiSight 1 Day Contact Lenses

By Staff
Thursday, January 16, 2020 12:21 AM SAN RAMON, Calif.—CooperVision, which is preparing for the March 2020 U.S. launch of MiSight 1 day contact lenses, has kicked off the new year by announcing this week the details of its comprehensive myopia management approach. An initial group of eyecare professionals (ECPs) gathered in Miami on Jan. 7-8 to learn about the “Brilliant Futures Myopia Management Program” and to prepare to prescribe the MiSight 1 day lens to patients. CooperVision’s MiSight 1 day lens is the first and only product approved by the Food and Drug Administration for slowing the progression of myopia when initially prescribed for children 8-12 years old, as VMAIL reported.

Staar Surgical Gains Supplemental Lens Approval for EVO Visian ICL

By Staff
Thursday, January 16, 2020 12:18 AM LAKE FOREST, Calif.—Staar Surgical has gained CE Mark approval for use of its ICL as a supplemental or “piggyback” lens in post-cataract IOL surgery patients (pseudophakics).

New Chair, Members Named to Eversight Board of Directors

By Staff
Thursday, January 16, 2020 12:15 AM ANN ARBOR, Mich.— Eversight has announced that two new members and a new chair have been named to its board of directors, effective Jan. 1, 2020. Eversight is a nonprofit organization with a mission to restore sight and prevent blindness through the healing power of donation, transplantation and research. Joining the Eversight board of directors are Carolyn Welsh, vice president & chief clinical officer, NJ Sharing Network, and Mahmoud N. Ghazzi, MD, Ph.D, MPH, an experienced researcher and biopharmaceutical consultant.

Staar Surgical Reports 4Q Net Sales Up 25 Percent

By Staff
Wednesday, January 15, 2020 12:24 AM LAKE FOREST, Calif.—Staar Surgical (NASDAQ: STAA) said yesterday that it expects fourth quarter and fiscal year net sales for the year ended Jan. 3, 2020 to increase approximately 25 percent and 21 percent over the prior year periods, respectively. Total net sales for the fourth quarter and fiscal year are expected to be approximately $38.9 million and $150.2 million, respectively, as compared to the company’s outlook for $37.6 million and $149.0 million most recently provided on Nov. 8, 2019.